Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

9.150 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Relay Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Dow, Nasdaq Futures Move Higher; All Eyes On Inflation Data ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording gains on Monday. The Dow Jones surged around 230 points, while the Nasdaq Composite jumped more... 
Via Benzinga
News headline image
Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008
From Foundation Medicine
Via Business Wire
News headline image
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 807 companies reached new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
News headline image
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
News headline image
Relay Therapeutics Shares Jump After Interim Data From Bile Duct Cancer Drug Ahead Of ESMO Presentation ↗
 
Via Benzinga
News headline image
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗
  
Via Benzinga
News headline image
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Relay Therapeutics Stock Shows Market Leadership With Jump To 94 RS Rating ↗
Relay Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 84 to 94. 
Via Investor's Business Daily
News headline image
Why Snowflake Is Trading Higher By 20%, Here Are 51 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50. 
Via Benzinga
News headline image
Salesforce, Dollar Tree, Tesla And Some Other Big Stocks Moving Lower On Thursday ↗
  Peloton Interactive, Inc. (NASDAQ: PTON) shares fell 20.8% to $10.68 after the company reported worse-than-expected Q4 sales results and issued Q1 sales guidance below estimates. 
Via Benzinga
News headline image
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company. 
Via Benzinga
News headline image
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Macy's, Palo Alto Networks And Other Big Gainers From Tuesday ↗
U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Looking Into Relay Therapeutics's Return On Capital Employed ↗
Relay Therapeutics (NASDAQ:RLAY) brought in sales totaling $365 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 23.76%, resulting in a loss of $76.79... 
Via Benzinga
News headline image
Gain Therapeutics: Reasons For Optimism ↗
In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage... 
Via Talk Markets
News headline image
Earnings Preview: Relay Therapeutics ↗
Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Relay... 
Via Benzinga
News headline image
Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
From Relay Therapeutics, Inc.
Via GlobeNewswire
News headline image
Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
Via Investor's Business Daily
News headline image
Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
Via Investor's Business Daily
News headline image
Analyst Ratings for Relay Therapeutics ↗
Over the past 3 months, 4 analysts have published their opinion on Relay Therapeutics (NASDAQ:RLAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
News headline image
Preview: Relay Therapeutics's Earnings ↗
Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Relay... 
Via Benzinga
News headline image
Best Biotech Stocks To Buy In 2022 ↗
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
News headline image
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? ↗
Can the formerly red-hot biotech segment return to its previous glory? 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Anixa Biosciences (NASDAQ:ANIX) s... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Jaguar Health (NASDAQ:JAGX) stock... 
Via Benzinga
News headline image
56 Biggest Movers From Yesterday ↗
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.